Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.
Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Garcia-Garcia HM, Waksman R. Haude M, et al. EClinicalMedicine. 2023 Apr 17;59:101940. doi: 10.1016/j.eclinm.2023.101940. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37113674 Free PMC article.
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.
Slagboom T, Toelg R, Witzenbichler B, Haude M, Masotti M, Ruiz Salmeron R, Witkowski AR, Uematus M, Takahashi A, Waksman R, Saito S. Slagboom T, et al. Among authors: haude m. EuroIntervention. 2023 Feb 20;18(14):1197-1200. doi: 10.4244/EIJ-D-22-00526. EuroIntervention. 2023. PMID: 36625005 Free PMC article. Clinical Trial. No abstract available.
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry.
Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Starmer G, Buck T, Haude M, Moccetti M, Wiemer M, Lee MK, Verheye S. Wlodarczak A, et al. Among authors: haude m. EuroIntervention. 2023 Jun 19;19(3):232-239. doi: 10.4244/EIJ-D-22-01069. EuroIntervention. 2023. PMID: 37226676 Free PMC article.
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.
Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Joner M, Toelg R, Wiemer M, Olivecrano G, Vermeersch P, Garcia-Garcia HM, Waksman R. Haude M, et al. EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326. EuroIntervention. 2023. PMID: 37334655 Free PMC article. Clinical Trial.
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
Valgimigli M, Wlodarczak A, Tölg R, Merkely B, Kelbæk H, Legutko J, Galli S, Godin M, Toth GG, Lhermusier T, Honton B, Dietrich PL, Stammen F, Ferdinande B, Silvain J, Capodanno D, Cayla G; Bioflow-DAPT Investigators. Valgimigli M, et al. Circulation. 2023 Sep 26;148(13):989-999. doi: 10.1161/CIRCULATIONAHA.123.065448. Epub 2023 Aug 25. Circulation. 2023. PMID: 37624364 Free PMC article. Clinical Trial.
Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold.
Garcia-Garcia HM, Waksman R, Melaku GD, Garg M, Beyene S, Wlodarczak A, Kerai A, Levine MB, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Haude M. Garcia-Garcia HM, et al. Among authors: haude m. Eur Heart J Cardiovasc Imaging. 2024 Mar 27;25(4):491-497. doi: 10.1093/ehjci/jead299. Eur Heart J Cardiovasc Imaging. 2024. PMID: 37936296 Clinical Trial.
Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.
Spirito A, Nussbaum J, Sartori S, Vogel B, Abizaid A, Cao D, Christiansen EH, Colombo A, de Winter RJ, Haude M, Kamaleldin K, Jakobsen L, Jensen LO, Krucoff MW, Landmesser U, Nardin M, Saito S, Smith KF, Suryapranata H, De Luca G, Dangas G, Mehran R; Mega-COMBO Collaboration. Spirito A, et al. Among authors: haude m. Am J Cardiol. 2023 Dec 15;209:52-54. doi: 10.1016/j.amjcard.2023.09.081. Epub 2023 Oct 20. Am J Cardiol. 2023. PMID: 37866281 No abstract available.
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study.
Seguchi M, Aytekin A, Xhepa E, Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Waksman R, Garcia-Garcia HM, Joner M. Seguchi M, et al. Among authors: haude m. EuroIntervention. 2024 Sep 16;20(18):e1173-e1183. doi: 10.4244/EIJ-D-24-00055. EuroIntervention. 2024. PMID: 39279514 Free article.
393 results